West Pharmaceutical Services Net Income 2010-2024 | WST

West Pharmaceutical Services annual/quarterly net income history and growth rate from 2010 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • West Pharmaceutical Services net income for the quarter ending December 31, 2024 was $0.130B, a 5.04% decline year-over-year.
  • West Pharmaceutical Services net income for the twelve months ending December 31, 2024 was $0.493B, a 16.97% decline year-over-year.
  • West Pharmaceutical Services annual net income for 2024 was $0.493B, a 16.97% decline from 2023.
  • West Pharmaceutical Services annual net income for 2023 was $0.593B, a 1.28% increase from 2022.
  • West Pharmaceutical Services annual net income for 2022 was $0.586B, a 11.47% decline from 2021.
West Pharmaceutical Services Annual Net Income
(Millions of US $)
2024 $493
2023 $593
2022 $586
2021 $662
2020 $346
2019 $242
2018 $207
2017 $151
2016 $144
2015 $96
2014 $127
2013 $112
2012 $81
2011 $76
2010 $65
2009 $73
West Pharmaceutical Services Quarterly Net Income
(Millions of US $)
2024-12-31 $130
2024-09-30 $136
2024-06-30 $111
2024-03-31 $115
2023-12-31 $137
2023-09-30 $161
2023-06-30 $155
2023-03-31 $140
2022-12-31 $103
2022-09-30 $121
2022-06-30 $189
2022-03-31 $174
2021-12-31 $148
2021-09-30 $176
2021-06-30 $187
2021-03-31 $151
2020-12-31 $98
2020-09-30 $82
2020-06-30 $91
2020-03-31 $74
2019-12-31 $64
2019-09-30 $56
2019-06-30 $66
2019-03-31 $55
2018-12-31 $52
2018-09-30 $55
2018-06-30 $56
2018-03-31 $44
2017-12-31 $0
2017-09-30 $51
2017-06-30 $39
2017-03-31 $61
2016-12-31 $39
2016-09-30 $38
2016-06-30 $45
2016-03-31 $22
2015-12-31 $33
2015-09-30 $2
2015-06-30 $28
2015-03-31 $33
2014-12-31 $31
2014-09-30 $31
2014-06-30 $38
2014-03-31 $27
2013-12-31 $24
2013-09-30 $27
2013-06-30 $30
2013-03-31 $32
2012-12-31 $21
2012-09-30 $15
2012-06-30 $16
2012-03-31 $29
2011-12-31 $19
2011-09-30 $17
2011-06-30 $20
2011-03-31 $20
2010-12-31 $6
2010-09-30 $18
2010-06-30 $22
2010-03-31 $20
2009-12-31 $20
2009-09-30 $17
2009-06-30 $20
2009-03-31 $15
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $15.984B $2.893B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.918B 20.77
Becton Dickinson (BDX) United States $66.130B 16.56
Cardinal Health (CAH) United States $30.812B 16.50
Straumann Holding AG (SAUHY) Switzerland $22.515B 0.00
Labcorp (LH) United States $21.029B 17.26
Cooper (COO) United States $17.974B 24.34
Align Technology (ALGN) United States $14.238B 27.05
Henry Schein (HSIC) United States $9.680B 18.44
Merit Medical Systems (MMSI) United States $6.033B 30.81
DENTSPLY SIRONA (XRAY) United States $3.787B 10.30
Patterson (PDCO) United States $2.744B 14.66
CONMED (CNMD) United States $1.915B 14.90
STAAR Surgical (STAA) United States $0.800B 0.00
Lifevantage (LFVN) United States $0.211B 23.38
Pro-Dex (PDEX) United States $0.108B 16.47